ToolGen Inc.

In News

Vertex, Crispr’s Casgevy Accused of Infringing New ToolGen Patent - Bloomberg Law News

Bloomberg Law News - Nov 19, 2025

ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY® - PR Newswire

PR Newswire - Nov 19, 2025

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics - Morningstar

Morningstar - Nov 24, 2025

Asia Deal Watch: Kelun And Crescent Partner And Cross-License Cancer Candidates - Citeline News & Insights

Citeline News & Insights - Dec 05, 2025

ToolGen and BarentsKrans step up CRISPR battle against Vertex - JUVE Patent

JUVE Patent - Sep 12, 2025

ToolGen sues Vertex over alleged unlicensed use of CRISPR tech in gene therapy - koreabiomed.com

koreabiomed.com - Apr 22, 2025

ToolGen and GenEditBio form cross-license deal for genome editing tech By Investing.com - Investing.com South Africa

Investing.com South Africa - Nov 24, 2025

A South Korean Company is Fighting to Stake its Claim in the CRISPR Patent Battle - Seed World

Seed World - Dec 14, 2023

Federal Circuit Revives CRISPR-Cas9 Patent Priority Dispute - Wilson Sonsini

Wilson Sonsini - May 16, 2025

ToolGen and Vertex focus battle over CRISPR/Cas therapy Casgevy in Europe - JUVE Patent

JUVE Patent - May 08, 2025

ToolGen Sues Lonza for Patent Infringement in Dutch Court - 동아사이언스

동아사이언스 - Sep 08, 2025

ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - ANP Persportaal

ANP Persportaal - Sep 08, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment